|May. 14, 2014|
Study: HPV-linked oral cancers may not be 'contagious'
Spouses and long-term partners of patients with HPV-related oral cancers appear to have no increased risk of oral HPV infections, according to the results of a new study led by Johns Hopkins investigators. Saliva samples taken from the partners of oral cancer patients did not contain elevated levels of HPV DNA, the researchers reported online in the Journal of Clinical Oncology.More
2014 ASCT Student Presentation Competition winners announced
American Society for Cytotechnology
Congratulations to the winners of the 2014 ASCT Student Presentation Competition held in Charleston, South Carolina, on April 26 during the ASCT Annual Conference. The Warren R. Lang Student Awards and the students' conference registration fees were provided by the ASCT Foundation. The Powerpoint files of the top presentations are available on the ASCT website, in the Student Forum. Click on the titles to view the files.
ASCT Student Presentation Winners: Jianhua Zhang (3rd), Alexandra Ferrara (2nd),
Sarah Zack (1st), Catherine Smith (Ed. Comm. Chair)
FDA approves new HPV screening method
The Food and Drug Administration has approved the first human papillomavirus test for primary cervical cancer screening: cobas. The test is for women 25 and older, and it can be used alone as a first step to decide if a woman needs additional testing to determine if she has cervical cancer. It can also be used to assess risk factors for developing cancer in the future.More
A single algorithm is phasing out the Pap smear
But the FDA's new approval of HPV testing changes two distinct features of how the test is used and promoted: It permits the use of an algorithm that enables the HPV test to be used on its own, and allows Roche to market its HPV test directly to consumers. Combined, those factors could spell the end of the Pap smear as we know it — a move that opponents say adds unnecessary confusion to an already complicated screening process, and jeopardizes women's health.More
HPV vaccine for boys: Some insurance companies deny coverage
A vital vaccine for kids may be covered for your daughter, but not for your son. Some insurance companies consider the HPV vaccine experimental for boys — even though it's recommended by the federal government as one of the best ways to prevent certain types of cancer later in life. More
Cultured red blood cells: There's nothing artificial about it
By Rosemary Sparacio
Blood transfusions play a critical role in clinical practice. Over 90 million transfusions take place each year. Transfusions are made possible throughout the U.S by donations from individuals, blood-donor programs, blood banks and the American Red Cross. However, in order to get the supplies they need, all venues must participate. Unfortunately, that is not always the case. The relatively short lifespan of donated blood, which is 120 days, demands that there is always a constant fresh supply. And even though there are testing parameters in place, there is always the risk of transmitting infections and the potential for incompatibility issues between donor and recipient.More
More STD screening on horizon for women?
A federal task force is poised to advise doctors to regularly screen all sexually active American women and girls up to age 24 for the sexually transmitted diseases chlamydia and gonorrhea, which often don't have outward symptoms. The U.S. Preventive Services Task Force hasn't made final decisions about the recommendations it will put forward to the nation's physicians. But the draft guidelines released recently represent a significant expansion of routine screening for STDs.More
Scientists discover second language in DNA
New insights into the human genome have led to the discovery of a second "code" or "language" within human DNA. Pathologists performing genetic testing will be particularly interested in the implications of this discovery, which the researchers have dubbed "duons." More
Study links data discrepancies with reported success of stem cell treatment
Researchers from Imperial College London conducted a meta-analysis of 49 randomized controlled trials of bone marrow stem cell therapy for heart disease. The study, published in the British Medical Journal, identified and listed over 600 discrepancies within the trial reports. More